| Molecular targeted therapies for renal cell carcinoma. | |
| | |
MedLine Citation:
|
PMID: 18163945 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
New advances in technology to directly target specific molecular events in the proliferation of cancer have led to promising results in renal cell carcinoma. Response rates in excess of 70% and complete responses in advanced (metastatic) renal cell carcinoma have caused a change in the paradigm of treatment from immunotherapy. Toxicities are significant, but manageable and pushing the toxicity to tolerability may increase the response rate. |
| | |
Authors:
|
Sam D Graham; Mary Elizabeth Warden; Jeffrey Lou |
Related Documents
:
|
11381825 - A survival analysis of metastatic breast cancer in pakistani patients. 22276005 - Male breast cancer: a review. 12908795 - Breast cancer metastatic to the choroid in a male patient: case report. 22729605 - Prostate cancer screening in eleusina. 435005 - Tamoxifen in advanced male breast cancer. 7986145 - Clinical implications of cervical lymph node metastasis patterns in thoracic esophageal... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Canadian journal of urology Volume: 14 Suppl 1 ISSN: 1195-9479 ISO Abbreviation: Can J Urol Publication Date: 2007 Dec |
Date Detail:
|
Created Date: 2007-12-31 Completed Date: 2008-03-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9515842 Medline TA: Can J Urol Country: Canada |
Other Details:
|
Languages: eng Pagination: 48-52 Citation Subset: IM |
Affiliation:
|
Urologic Specialists of Virginia, Richmond, VA 23225, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
therapeutic use* Carcinoma, Renal Cell / drug therapy* Humans Immunotherapy / methods* Kidney Neoplasms / drug therapy* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Current management of small renal masses.
Next Document: Medical management of benign prostatic hypertrophy.